MarginsXMarginsX
Home › Markets › Health Care › GMED

Globus Medical Inc. (GMED)

GMED trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$70.50
-2.27% on the day
Market cap
$9.3B
Mid cap
Revenue · 2025
$2.9B
+16.7% on 2024
Net income · 2025
$537.9M
18.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGMED on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2012
SEC CIK0001237831
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.9B
Net income$537.9M
Operating income$479.8M
Net margin18.3%
Operating margin16.3%
Revenue growth+16.7%
Cash$526.2M
Total assets$5.3B
P/E (computed)17.4×
P/S (computed)3.2×

Warning signs

Cash runway
Cash-flow positive
$441.3M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$17.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$441.3M cash; operating cash flow $231.5M a quarter.Report 2026-09-30
Shares outstanding132,471,693 (2026-11-02).Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $17.5M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$763.7M$141.2M$265.2M$441.3MNo debt tags$3.1B10-Q 2026-11-05
Q2 2026
2026-06-30
$789.6M$151.6M$209.7M$507.7MNo debt tags$3.1B10-Q 2026-08-06
Q1 2026
2026-03-31
$759.9M$124.3M$202.4M$561.0MNo debt tags$3.1B10-Q 2026-05-07
Q4 2025
2025-12-31
$826.4M$140.6M$248.6M$526.2MNo debt tags$2.9B10-K 2026-02-24
Q3 2025
2025-09-30
$769.0M$119.0M$249.7M$371.8MNo debt tags$2.8B10-Q 2026-11-05
Q2 2025
2025-06-30
$745.3M$202.8M$77.9M$229.4MNo debt tags$2.6B10-Q 2026-08-06
Q1 2025
2025-03-31
$598.1M$75.5M$177.3M$461.3MNo debt tags$2.5B10-Q 2026-05-07
Q4 2024
2024-12-31
$657.3M$26.5M$210.3M$784.4MNo debt tags$2.5B10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32023-03-28
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 780 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.5%
1 month-5.5%
3 months-16.1%
Year to date-17.4%
1 year-14.1%
From 52-week high-25.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PODDInsulet Corporation$145.29-4.72%$10.1B
PENPenumbra Inc.$320.62-0.09%$12.6B
BAXBaxter International Inc.$25.54-1.05%$13.2B
TFXTeleflex Incorporated$157.10+1.51%$6.2B
GKOSGlaukos Corporation$244.88-0.34%$14.5B
SOLVSolventum Corporation$88.65-0.48%$15.0B
HAEHaemonetics Corporation$121.34-1.30%$5.5B
MMEDMiniMed Group Inc.$18.65+3.67%$5.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier